Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 1-year average of -8861.99%, near the high end of its 1-year range (-35447.97%–0.00%).
100.00% above its 12-month average of -11815.99%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -35447.97%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
-11815.99%
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 784 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Parabilis Medicines, Inc.
Market Cap
$3.34B
Net Profit Margin
0.00%
TTM Avg
-11815.99%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.39B
Net Profit Margin
33.42%
TTM Avg
30.07%
3Y Avg
2.48%
5Y Avg
-14.75%
Market Cap
$3.41B
Net Profit Margin
-6755.78%
TTM Avg
-10397.28%
3Y Avg
-7288.11%
5Y Avg
-5606.97%
Market Cap
$3.49B
Net Profit Margin
-4612.13%
TTM Avg
-2306.07%
3Y Avg
-1485.27%
5Y Avg
-1076.43%
Market Cap
$3.49B
Net Profit Margin
-74.75%
TTM Avg
-1986.54%
3Y Avg
-1142.83%
5Y Avg
-820.99%
Market Cap
$3.54B
Net Profit Margin
-1.69%
TTM Avg
-12.55%
3Y Avg
-19.61%
5Y Avg
-21.06%
Market Cap
$3.09B
Net Profit Margin
-14191.20%
TTM Avg
0.00%
3Y Avg
-86.13%
5Y Avg
-153.41%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Parabilis Medicines, Inc. (PBLS) | $3.34B | 0.00% | -11815.99% | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.39B | 33.42% | 30.07% | 2.48% | -14.75% |
| CareDx, Inc (CDNA)vs › | $3.40B | 24.23% | 5.06% | -20.39% | -16.94% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.41B | -6755.78% | -10397.28% | -7288.11% | -5606.97% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.49B | -4612.13% | -2306.07% | -1485.27% | -1076.43% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.49B | -74.75% | -1986.54% | -1142.83% | -820.99% |
| Celcuity Inc. (CELC)vs › | $3.49B | 0.00% | 0.00% | 0.00% | 0.00% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.54B | -1.69% | -12.55% | -19.61% | -21.06% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.09B | -14191.20% | 0.00% | -86.13% | -153.41% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.03B | 0.00% | -172.68% | -306.20% | -1288.24% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -35447.97% |
| 2026-03-31 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
